A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma. (Record no. 3547991)

MARC details
000 -LEADER
fixed length control field 01283 a2200361 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512060325.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198703s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0344-5704
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/BF00273405
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cantwell, B M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19870323
245 00 - TITLE STATEMENT
Title A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. 1986
300 ## - PHYSICAL DESCRIPTION
Extent 286-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carboplatin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mesothelioma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pleural Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Random Allocation
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Franks, C R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Harris, A L
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 18
-- no. 3
-- p. 286-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/BF00273405">https://doi.org/10.1007/BF00273405</a>
Public note Available from publisher's website

No items available.